LHR Consult’s target group is intended to cover the healthcare business (e.g. fertility clinics, cell and tissue banks, general practitioners and hospitals), life science and other academic disciplines of the public/private sector, for whom individual or combined services may be relevant.
The fertility-/life science industry plays an important role for the Danish economy by boosting growth and contributing financially to the welfare society. Especially the global fertility market is expected to witness significant growth in the coming years. This is on account of factors such as growing prevalence of male and female infertility, surging social acceptance and awareness among the population, as well as growing advancement and adoption of new assisted reproductive procedures.
Denmark is one of the largest exporters of human sperm globally and two of the key market players of the sperm bank industry are the Danish companies Cryos International and European Sperm Bank. Thus, as a result of the local presence, favorable government law, and relatively low cost of treatment, the global growth is expected to affect the Danish market significantly.
The pharmaceutical/biotech industry is also a key sector of the Danish economy. Denmark has a considerable biopharmaceutical industry, with several domestic companies researching and manufacturing pharmaceutical products. Revenues generated has increased significantly over the past years.
The Danish pharma and biotech industry is also among the best and most innovative in the world. A number of favourable framework conditions means that a fast, safe and cost-effective drug discovery and drug development is a reality in Denmark.